
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A regional healthcare provider in the UK seeks a Rheumatology Specialist Physiotherapist to provide expert physiotherapy assessment and management for rheumatological conditions. The role involves leading clinics, coordinating MSK team training, and contributing to Trust training development. Key benefits include flexible working, NHS Pension Scheme, and generous annual leave. The ideal candidate will collaborate closely with a multidisciplinary team to improve patient outcomes.
This post is for 37.5 hours and covers clinics across Tameside and Glossop. It involves providing expert physiotherapy assessment, diagnosis, and management for patients with rheumatological and other musculoskeletal conditions, ensuring evidence‑based care and supporting multidisciplinary team collaboration. You will act as the first point of clinical contact for patients presenting with undifferentiated musculoskeletal conditions in primary care settings.
Tameside and Glossop Integrated Care NHS Foundation Trust serves a community of 250,000 people across Tameside & Glossop. We provide a range of services both within the hospital and across our community for both adults and children. Our vision is to improve health outcomes for our population and influence wider determinants of health through collaboration with our health & care partners.
We actively encourage applications irrespective of race, age, disability, sex, gender reassignment, gender identity or expression, sexual orientation, religion or belief, marriage & civil partnership, or pregnancy or maternity. Recognising those communities that are under‑represented within our workforce, we would particularly welcome applications from Black, Asian & minority ethnic candidates, LGBTQ+ & Disabled people.
The person specification below is not the full personspecification, but outlines the criteria against which your application form will be assessed.
This advert closes on Monday 29 Dec 2025.